World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
56
Citations
12149
World Ranking
3692
National Ranking
1450

Overview

James J. Rahal is affiliated with New York Hospital Queens in the United States. Their professional profile reflects a current active status in the medical or scientific community without indications of retirement or deceased status.

There is no available information regarding specific research papers published by James J. Rahal. Consequently, no details about publication years, venues, or citation counts are documented in current records.

No frequent co-authors have been identified, which indicates either a limited collaborative publication history or unreported co-authorship data.

Similarly, there are no known frequent publication venues associated with Rahal's work, implying a lack of recorded concentration in specific journals or conferences.

Records show no book publications attributed to James J. Rahal in terms of publisher affiliations or notable works.

The scientist's main fields of study, subfields, and main topics of work are not provided, which suggests insufficient public or indexed information about their specialized areas of research or academic focus.

There are no awards or honors documented for James J. Rahal, indicating either no publicly recorded recognitions or a lack of entry in the available datasets.

Best Publications

  • Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella

    James J. Rahal;Carl Urban;David Horn;Katherine Freeman

  • Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins

    Kenneth S. Meyer;Carl Urban;Janet A. Eagan;Barbara J. Berger

  • Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

    Abigail Zuger;Eddie Louie;Robert S. Holzman;Michael S. Simberkoff

  • Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

    P A Bradford;C Urban;N Mariano;S J Projan

  • Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City

    Patricia A. Bradford;Simona Bratu;Carl Urban;Melissa Visalli

  • Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

    E.S Go;C Urban;J Burns;N Mariano

  • Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.

    Carl Urban;Sorana Segal-Maurer;James J. Rahal

  • Surgical reconstruction of TMJ.

    John F Anderson;James J Rahal

  • FUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE

    Unknown

  • In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii

    Jimmy Yoon;Carl Urban;Christian Terzian;Noriel Mariano

  • Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure.

    Michael S. Simberkoff;Wafaa El Sadr;Gerald Schiffman;James J. Rahal

  • Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens

    James J. Rahal;Michael S. Simberkoff

  • Effect of Sulbactam on Infections Caused by Imipenem-Resistant Acinetobacter calcoaceticus Biotype anitratus

    Carl Urban;Eddie Go;Noriel Mariano;Barbara J. Berger

  • Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species

    James J. Rahal

  • SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

    Patricia A. Bradford;Carl Urban;Arun Jaiswal;Noriel Mariano

  • Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

    Helio S. Sader;Paul D. Fey;Douglas N. Fish;Ajit P. Limaye

  • Fluoroquinolone-Resistant Streptococcus pneumoniae Associated with Levofloxacin Therapy

    Carl Urban;Naim Rahman;Xilin Zhao;Noriel Mariano

  • In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

    Carl Urban;Noriel Mariano;James J. Rahal;James J. Rahal

  • Effect of Combined Therapy with Ansamycin, Clofazimine, Ethambutol, and Isoniazid for Mycobacterium avium Infection in Patients with AIDS

    Agins Bd;Berman Ds;Spicehandler D;el-Sadr W

  • Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients.

    James J. Rahal;Phineas J. Hyams;Michael S. Simberkoff;Ethan Rubinstein

  • Nosocomial Antibiotic Resistance in Multiple Gram-Negative Species: Experience at One Hospital with Squeezing the Resistance Balloon at Multiple Sites

    James J. Rahal;Carl Urban;Sorana Segal-Maurer

Frequent Co-Authors

Michael S. Simberkoff
Michael S. Simberkoff New York University
Daniel S. Berman
Daniel S. Berman Cedars-Sinai Medical Center
Karl Drlica
Karl Drlica Rutgers, The State University of New Jersey
Karen Bush
Karen Bush Indiana University
Patricia A. Bradford
Patricia A. Bradford AstraZeneca (United Kingdom)
Ronald N. Jones
Ronald N. Jones JMI Laboratories
Ajit P. Limaye
Ajit P. Limaye University of Washington
Michael J. Rybak
Michael J. Rybak Wayne State University
Ken B. Waites
Ken B. Waites University of Alabama at Birmingham
David R. Snydman
David R. Snydman Tufts Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to diverse career paths, many of which can be enhanced through additional qualifications. For example, exploring easy mph online programs can complement microbiology skills with public health knowledge, creating opportunities in epidemiology and health policy.

Careers like becoming a child life specialists salary link clinical understanding with emotional support, demonstrating how microbiology graduates might pivot towards health-related social services. Understanding salary ranges and job demands can help guide this transition effectively.

For individuals facing unique challenges, including those with prior records, online education remains accessible. The resource on college degrees for felons highlights valuable degree options and opportunities in the health sciences, ensuring education is inclusive and attainable.

Additionally, roles such as a functional medicine nurse salary show the potential for microbiology graduates to expand into practical, patient-focused healthcare fields, combining scientific knowledge with holistic patient care.

Best Scientists Citing James J. Rahal

Trending Scientists